Literature DB >> 22153298

Conservation of the DENV-2 type-specific and DEN complex-reactive antigenic sites among DENV-2 genotypes.

Trevor J Pitcher1, Gregory D Gromowski, David W C Beasley, Alan D T Barrett.   

Abstract

The envelope (E) protein is composed of three domains (ED1, ED2 and ED3) with ED3 targeted by the most potent neutralizing antibodies. DENV-2 strains can be divided into six genotypes. Comparison of ED3 of representative strains of the six genotypes revealed that there are nine variable residues that are specific to a given genotype. Recombinant ED3s (rED3s) of six different DENV-2 strains representing all nine variable residues were expressed, and their reactivity against a panel of two DENV-2 type-specific and three DENV complex-reactive monoclonal antibodies (mAbs) were compared. The differences in binding affinity to the rED3s representing different DENV-2 genotypes were relatively small, with the exception of type-specific-mAb 3H5 that showed up to 10-fold differences in binding between genotypes. Overall the binding differences did not lead to detectable differences in neutralization. Based on these results, DENV-2 ED3-specific neutralizing antibodies will likely be effective against DENV-2 strains from all six genotypes.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22153298      PMCID: PMC4142575          DOI: 10.1016/j.virol.2011.10.020

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells.

Authors:  W D Crill; J T Roehrig
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  Structure of dengue virus: implications for flavivirus organization, maturation, and fusion.

Authors:  Richard J Kuhn; Wei Zhang; Michael G Rossmann; Sergei V Pletnev; Jeroen Corver; Edith Lenches; Christopher T Jones; Suchetana Mukhopadhyay; Paul R Chipman; Ellen G Strauss; Timothy S Baker; James H Strauss
Journal:  Cell       Date:  2002-03-08       Impact factor: 41.582

Review 3.  Flavivirus genome organization, expression, and replication.

Authors:  T J Chambers; C S Hahn; R Galler; C M Rice
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

4.  Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.

Authors:  D M Watts; K R Porter; P Putvatana; B Vasquez; C Calampa; C G Hayes; S B Halstead
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

5.  The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution.

Authors:  F A Rey; F X Heinz; C Mandl; C Kunz; S C Harrison
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

6.  Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Authors:  M K Gentry; E A Henchal; J M McCown; W E Brandt; J M Dalrymple
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

7.  Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution.

Authors:  C M Rice; E M Lenches; S R Eddy; S J Shin; R L Sheets; J H Strauss
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

8.  Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape.

Authors:  Gregory D Gromowski; John T Roehrig; Michael S Diamond; J Ching Lee; Trevor J Pitcher; Alan D T Barrett
Journal:  Virology       Date:  2010-09-15       Impact factor: 3.616

9.  An external loop region of domain III of dengue virus type 2 envelope protein is involved in serotype-specific binding to mosquito but not mammalian cells.

Authors:  Jan-Jong Hung; Meng-Ti Hsieh; Ming-Jer Young; Chuan-Liang Kao; Chwan-Chuen King; Wen Chang
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Phylogenetic relationships and differential selection pressures among genotypes of dengue-2 virus.

Authors:  S Susanna Twiddy; Jeremy J Farrar; Nguyen Vinh Chau; Bridget Wills; Ernest A Gould; Tamara Gritsun; Graham Lloyd; Edward C Holmes
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

View more
  7 in total

1.  Dengue vaccine-induced CD8+ T cell immunity confers protection in the context of enhancing, interfering maternal antibodies.

Authors:  Jian Hang Lam; Yen Leong Chua; Pei Xuan Lee; Julia María Martínez Gómez; Eng Eong Ooi; Sylvie Alonso
Journal:  JCI Insight       Date:  2017-12-21

2.  Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues.

Authors:  Trevor J Pitcher; Vanessa V Sarathy; Kiyohiko Matsui; Gregory D Gromowski; Claire Y-H Huang; Alan D T Barrett
Journal:  J Gen Virol       Date:  2014-10-22       Impact factor: 3.891

3.  The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1.

Authors:  Yang Zhou; S Kyle Austin; Daved H Fremont; Boyd L Yount; Jeremy P Huynh; Aravinda M de Silva; Ralph S Baric; William B Messer
Journal:  Virology       Date:  2013-02-28       Impact factor: 3.616

4.  The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.

Authors:  Phong D Lee; Swati Mukherjee; Melissa A Edeling; Kimberly A Dowd; S Kyle Austin; Carolyn J Manhart; Michael S Diamond; Daved H Fremont; Theodore C Pierson
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

5.  Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.

Authors:  Jedhan U Galula; Wen-Fan Shen; Shih-Te Chuang; Gwong-Jen J Chang; Day-Yu Chao
Journal:  J Virol       Date:  2014-07-09       Impact factor: 5.103

6.  Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope.

Authors:  S Kyle Austin; Kimberly A Dowd; Bimmi Shrestha; Christopher A Nelson; Melissa A Edeling; Syd Johnson; Theodore C Pierson; Michael S Diamond; Daved H Fremont
Journal:  PLoS Pathog       Date:  2012-10-04       Impact factor: 6.823

7.  Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses.

Authors:  Rodrigo A Maillard; Tong Liu; David W C Beasley; Alan D T Barrett; Vincent J Hilser; J Ching Lee
Journal:  J Am Chem Soc       Date:  2014-07-08       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.